US 12,435,035 B2
Nanomaterials
Gregory Lawrence Hamilton, Atlanta, GA (US); Neeraj Narendra Patwardhan, Atlanta, GA (US); Cory Dane Sago, Atlanta, GA (US); Mina Fawzy Gaballa Shehata, Dunwoody, GA (US); and Milloni Balwantkumar Chhabra, Dunwoody, GA (US)
Assigned to Guide Therapeutics, LLC, Cambridge, MA (US)
Filed by Guide Therapeutics, LLC, Cambridge, MA (US)
Filed on Jan. 6, 2021, as Appl. No. 17/142,595.
Claims priority of provisional application 62/958,876, filed on Jan. 9, 2020.
Prior Publication US 2021/0230112 A1, Jul. 29, 2021
Int. Cl. C07D 205/04 (2006.01); A61K 9/1271 (2025.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); C07C 229/30 (2006.01); C07D 207/06 (2006.01); C07D 207/09 (2006.01); C07D 211/14 (2006.01); C07D 211/34 (2006.01); C07D 265/30 (2006.01); C07D 295/145 (2006.01); C07D 319/06 (2006.01); C07D 401/04 (2006.01); C07D 405/12 (2006.01); C07D 471/04 (2006.01); C07D 487/08 (2006.01); A61K 9/51 (2006.01); B82Y 5/00 (2011.01); B82Y 30/00 (2011.01); B82Y 40/00 (2011.01); C07C 219/22 (2006.01); C07D 207/08 (2006.01); C07D 207/14 (2006.01); C07D 207/16 (2006.01); C07D 211/58 (2006.01); C07D 211/62 (2006.01); C07D 213/36 (2006.01); C07D 241/04 (2006.01); C07D 243/08 (2006.01); C07D 295/088 (2006.01); C07D 295/096 (2006.01); C07D 295/13 (2006.01); C07D 295/15 (2006.01); C07D 451/06 (2006.01); C07D 455/02 (2006.01)
CPC C07D 205/04 (2013.01) [A61K 9/1271 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); C07C 229/30 (2013.01); C07D 207/06 (2013.01); C07D 207/09 (2013.01); C07D 211/14 (2013.01); C07D 211/34 (2013.01); C07D 265/30 (2013.01); C07D 295/145 (2013.01); C07D 319/06 (2013.01); C07D 401/04 (2013.01); C07D 405/12 (2013.01); C07D 471/04 (2013.01); C07D 487/08 (2013.01); A61K 9/5123 (2013.01); B82Y 5/00 (2013.01); B82Y 30/00 (2013.01); B82Y 40/00 (2013.01); C07C 219/22 (2013.01); C07D 207/08 (2013.01); C07D 207/14 (2013.01); C07D 207/16 (2013.01); C07D 211/58 (2013.01); C07D 211/62 (2013.01); C07D 213/36 (2013.01); C07D 241/04 (2013.01); C07D 243/08 (2013.01); C07D 295/088 (2013.01); C07D 295/096 (2013.01); C07D 295/13 (2013.01); C07D 295/15 (2013.01); C07D 451/06 (2013.01); C07D 455/02 (2013.01)] 2 Claims
 
1. A compound having the following structure:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.